Sort
130,381 grants matching “hiv”
HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-Targeted HAART
$1,053,952Ronald J. Ellis · University Of California, San Diego · R01 · FY2006 · MH
NIAID DAIDS Clinical Bio-reagent Center (CBC)
$1,053,843National Institute Of Allergy And Infectious Diseases · Y01 · FY2014 · AI
INCREASE ACCESS TO HIV COUNSELING, TESTING IN SOUTH AFRICA
$1,053,716Melusi Ndhlalambi · African Medical And Research Foundation · U2G · FY2009 · PS
EXPANDED HIV TESTING PREVELANCE HEALTH CARE SETTINGS TO ADDRESS RACIAL/ETHIC DISP
$1,053,670Liisa Randall · Michigan State Department Of Health And Human Services · U62 · FY2009 · PS
Scale It Up Management Core
$1,053,666Bonita Francess Stanton · Florida State University · U19 · FY2017 · HD
Molecular Genetics Of Mammalian Retrovirus Replication
$1,053,638Judith G Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
Next Generation Pre-exposure Prophylaxis
$1,053,496J. Victor Garcia-Martinez · Univ Of North Carolina Chapel Hill · R01 · FY2013 · AI
India International Center for Excellence in Research
$1,053,276Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Chicago Clinical Trials Unit
$1,053,181Chad J Achenbach · Northwestern University At Chicago · UM1 · FY2024 · AI
Project Horizon: Hydrogel Injectable Depot System for Next-Generation Long-Acting HIV Prevention and Contraception
$1,052,992Meredith R Clark · Eastern Virginia Medical School · R61 · FY2019 · AI
Project Horizon: Hydrogel Injectable Depot System for Next-Generation Long-Acting HIV Prevention and Contraception
$1,052,953Meredith R Clark · Eastern Virginia Medical School · R61 · FY2021 · AI
Novel pre-coital, non-hormonal multipurpose prevention technology (MPT)
$1,052,922Pavimol Angsantikul · Population Council · R01 · FY2021 · AI
Synthesis of Therapeutic Agents for Treatment of Infectious Diseases
$1,052,509Walter Powell · Starks Associates, Inc. · N01 · FY2010 · AI
Structure and Function of HIV-1 Reverse Transcriptase
$1,052,495Stephen H Hughes · Basic Sciences · Z01 · FY2007 · CA
HIV neutralization and mechanisms of cellular entry
$1,052,305Sriram Subramaniam · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Technology Development for 3D Electron Microscopy
$1,052,305Sriram Subramaniam · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Resource for NMR Molecular Imaging of Proteins
$1,052,237Stanley J Opella · University Of California, San Diego · P41 · FY2011 · EB
NIAID Preclinical Development Support
$1,052,178Advanced Bioscience Laboratories, Inc. · N01 · FY2012 · AI
Polyclonal Bi-Specific Vectored ImmunoTherapy to Functionally Cure HIV Infection
$1,052,100Alejandro Benjamin Balazs · Massachusetts General Hospital · DP1 · FY2025 · DA
Polyclonal Bi-Specific Vectored ImmunoTherapy to Functionally Cure HIV Infection
$1,052,100Alejandro Benjamin Balazs · Massachusetts General Hospital · DP1 · FY2024 · DA
Herpesviruses as Vaccine Vectors for AIDS
$1,052,099Harvard University (Medical School) · P01 · FY2005 · AI
HCV and Progression of HIV and HAART Response in Women
$1,052,064University Of Southern California · R01 · FY2002 · AI
Adjustment Problems and Substance Use in 3 Generations
$1,052,036Deborah M. Capaldi · Oregon Social Learning Center, Inc. · R01 · FY2009 · DA
Center for Prevention Implementation Methods for Drug Abuse & Sex Risk Behavior
$1,051,915C. Hendricks Brown · University Of Miami School Of Medicine · P30 · FY2012 · DA
GH11-1150, MEDICAL MALE CIRCUMCISION (MMC) FOR HIV PREVENTION IN KWAZULU NATAL
$1,051,881Nikki Soboil · Sactwu Aids Project · U2G · FY2014 · GH